Expanding the treatment arsenal in glaucoma management

News
Podcast

In this episode, four expert faculty talk about the importance of early diagnosis and treatment of thyroid eye disease. They discuss the differential diagnosis, screening tests, and the need for multidisciplinary management for these patients.

Glaucoma remains a leading cause of irreversible blindness globally as progressive optic nerve damage leads to permanent vision loss. Recent advancements in glaucoma management—including novel mechanisms of action, innovative drug delivery systems, and minimally invasive glaucoma surgeries—may help improve adherence, efficacy, and outcomes.

This PER On Air Optometry Times podcast provides an in-depth review of some of the key highlights from the 18th Annual Controversies in Modern Eye Care Conference, held in May 2024. This unique and engaging multi-media activity focuses on the practical aspects of managing patients with glaucoma, putting recent clinical trial data into clinical context. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did.

Inder Paul Singh, MD

President

The Eye Centers of Racine and Kenosha

Racine, WI

Deborah Ristvedt, DO

Anterior Segment Surgeon

Vance Thompson Vision

Alexandria, MN

Arsham Sheybani, MD

Associate Professor of Ophthalmology and Visual Sciences

Washington University School of Medicine in St Louis

St Louis, MO

Melissa Tawa, OD, FAAO

Assistant Professor

Jarnagin Center for Primary Eye Care and

Ocular Disease Service

University Eye Center at Ketchum Health

Marshall B. Ketchum University

Anaheim, CA

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.
Karl Stonecipher ASCRS 2025
AnnMarie Hipsley, DPT, PhD, at ASCRS 2025
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
At ASCRS 2025, Alex Hacopian, MD, shares information from his presentation on next-gen presbyopia-correcting intraocular lenses.
© 2025 MJH Life Sciences

All rights reserved.